Clearance Summary
FERRITIN-LATEX, MODELS 1418-2070, 1418-0279 received FDA 510(k) clearance under submission number K062746, sponsored by Medicon Hellas S.A. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2006-11-20.
- Submission: K062746
- Applicant / Sponsor: Medicon Hellas S.A
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5340
- Decision date: 2006-11-20
Classification & Regulation
This clearance is catalogued under FDA product code DBF and 21 CFR 866.5340, within the Immunology review panel as a Class II device.